KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Other Non-Current Assets: 2018-2025

Historic Other Non-Current Assets for Twist Bioscience (TWST) over the last 7 years, with Sep 2025 value amounting to $4.9 million.

  • Twist Bioscience's Other Non-Current Assets rose 74.08% to $4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 million, marking a year-over-year increase of 74.08%. This contributed to the annual value of $4.9 million for FY2025, which is 74.08% up from last year.
  • Per Twist Bioscience's latest filing, its Other Non-Current Assets stood at $4.9 million for Q3 2025, which was up 26.31% from $3.9 million recorded in Q2 2025.
  • Over the past 5 years, Twist Bioscience's Other Non-Current Assets peaked at $7.7 million during Q3 2021, and registered a low of $2.4 million during Q1 2023.
  • In the last 3 years, Twist Bioscience's Other Non-Current Assets had a median value of $4.9 million in 2025 and averaged $4.4 million.
  • As far as peak fluctuations go, Twist Bioscience's Other Non-Current Assets surged by 171.84% in 2021, and later tumbled by 65.73% in 2023.
  • Over the past 5 years, Twist Bioscience's Other Non-Current Assets (Quarterly) stood at $7.4 million in 2021, then slumped by 60.65% to $2.9 million in 2022, then surged by 85.42% to $5.4 million in 2023, then slumped by 36.42% to $3.4 million in 2024, then surged by 74.08% to $4.9 million in 2025.
  • Its last three reported values are $4.9 million in Q3 2025, $3.9 million for Q2 2025, and $3.7 million during Q1 2025.